Project Grant F31DA063318

Award Date 10/17/25
Completion Date Not listed
Dollars Obligated $49K
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $722,876 to New York University School of Medicine to conduct a study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The study aims to: 1) characterize real-world trajectories of OUD treatment in the year following hospital encounters among treatment-naive individuals and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), totaling $444,826, is focused on adapting and testing an innovative, trauma-informed intervention to reduce overdose risk among women re-entering the community from prison. The key activities include: 1) Adapting the Trust-Based Relational Intervention (TBRI) approach by engaging stakeholders to align it with the unique needs of justice-involved women,...
This $385,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to advance integrated treatment for co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD) in real-world settings. The key objectives are to: Assess the effectiveness of integrated treatment approaches, including first-line medications and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), for patients with co-occurring OUD...
This federal Project Grant award of $2,332,500 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The objective of this 4-year project is to build a "prison learning health system" to improve the quality, efficiency, and reach of HIV, HIV risk, and substance use disorder (SUD) care in Washington state prisons. Key innovations include: 1) establishing quality metrics and a patient advisory board to guide...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $823,809 to the University of Pittsburgh to develop and validate a suite of multidimensional measures of access to Medications for Opioid Use Disorder (MOUD) across U.S. states and the District of Columbia. The primary objectives are to: Create a Small Area Multidimensional MOUD Access (SAMMA) measure suite using public data sources. Validate and...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) provides $541,080 to The Trustees of Columbia University in the City of New York to conduct a randomized controlled trial examining the use of extended-release injectable buprenorphine versus sublingual buprenorphine/naloxone in treating opioid use disorder (OUD) among individuals who use high-potency synthetic opioids. The key objectives are to compare abstinence and...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,360,092 to The Medical University of South Carolina to conduct a study titled "Real-World Assessment of Social Functioning During OUD Treatment: Integrating Reports from Patients and Their Concerned Significant Others." The study aims to examine how affiliative social engagement behaviors, social reward, and social connection...
This federal Project Grant award of $683,583 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to estimate the potential impacts of four alternative methadone treatment (MT) policy scenarios in New York State. The project will use an agent-based computer simulation model to analyze how changes to MT access points, such as through OTPs, mobile units, prescribers, and pharmacies, could influence methadone...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $196,236 to The Washington University to conduct research focused on disparities in the prescription and effectiveness of medications to treat opioid use disorder (OUD) during pregnancy. The key objectives of the 5-year project are to: 1) evaluate how race and racial segregation are associated with the use of buprenorphine and methadone as well...
This $4.68 million project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, will fund research under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The University of Michigan will conduct a prospective cohort study of 400 adults with opioid-involved polysubstance use in Michigan. Researchers will collect detailed weekly data on participants' substance use patterns and motivations over four weeks to understand nuanced profiles...

IMPROVING ACCESS AND LINKAGE TO SUBSTANCE USE TREATMENT FOR FORMERLY INCARCERATED PERSONS APPLYING A COMPLEX SYSTEMS APPROACH - PROJECT SUMMARY THIS PROJECT AIMS TO ENHANCE THE HEALTH AND WELL-BEING OF INDIVIDUALS TRANSITIONING FROM CORRECTIONAL FACILITIES TO COMMUNITY SETTINGS BY ADDRESSING BARRIERS TO ACCESSING AND ENGAGING IN MEDICATIONS FOR OPIOID USE DISORDER (MOUD) TREATMENT USING AN INNOVATIVE COMPLEX SYSTEMS APPROACH. A COMPLEX SYSTEMS APPROACH AIMS TO ADDRESS SOCIAL DETERMINANTS OF HEALTH AND EXPRESSLY ACKNOWLEDGES THAT ACHIEVING HEALTH EQUITY REQUIRES MORE THAN JUST INDIVIDUAL INTERVENTIONS; IT NECESSITATES SYSTEMIC CHANGES THAT IMPROVE COORDINATION, COMMUNICATION, AND RESOURCE ALLOCATION ACROSS VARIOUS ORGANIZATIONS AND AGENCIES INVOLVED IN THE REENTRY PROCESS. THIS APPROACH FOCUSES ON TRANSFORMING THE INTERCONNECTED COMPONENTS OF THE REENTRY SYSTEM TO CREATE A SUPPORTIVE ENVIRONMENT THAT FACILITATES CONTINUOUS AND EFFECTIVE ACCESS TO MOUD TREATMENT. SPECIFIC AIMS INCLUDE: 1) EXAMINATION OF THE STRUCTURE AND FUNCTION OF ORGANIZATIONAL NETWORKS AND STRENGTH OF RELATIONSHIPS AMONG ORGANIZATIONS THAT PROVIDE REENTRY AND LINKAGE SERVICES FOR MOUD TREATMENT, 2) PROVIDER PERSPECTIVES ON HOW NETWORK CONNECTIVITY AND MULTI-LEVEL INTERACTIONS IMPACT LINKAGE FOR MOUD TREATMENT, AND 3) PERSPECTIVES OF FORMERLY INCARCERATED INDIVIDUALS WITH CURRENT OR PRIOR ILLICIT OPIOID USE ON INTERACTIONS WITH THE COMPLEX REENTRY SYSTEM FOR LINKAGE TO MOUD TREATMENT. THE RESEARCH DESIGN EMPLOYS A MULTI-METHOD APPROACH, COMBINING QUANTITATIVE AND QUALITATIVE DATA COLLECTION AND ANALYSIS. QUANTITATIVE DATA WILL BE COLLECTED FROM ORGANIZATIONAL LEADERS AND REENTRY SERVICE PROVIDERS USING A NETWORK SURVEY CONSISTING OF A NETWORK INVENTORY AND A RELATIONAL COORDINATION ASSESSMENT. QUALITATIVE DATA WILL BE GATHERED THROUGH IN-DEPTH INTERVIEWS WITH REENTRY SERVICE PROVIDERS AND FORMERLY INCARCERATED INDIVIDUALS, FOCUSING ON THEIR EXPERIENCES WITH ACCESS AND LINKAGE TO MOUD TREATMENT. THE PROJECT WILL UTILIZE COMPLEX SYSTEMS AND ORGANIZATIONAL NETWORK ANALYSIS TO UNDERSTAND THE STRUCTURE AND DYNAMICS OF REENTRY ORGANIZATIONS INVOLVED IN MOUD LINKAGE AND TREATMENT. THE FINDINGS WILL INFORM THE DEVELOPMENT OF POLICY RECOMMENDATIONS AND INTERVENTION STRATEGIES AIMED AT IMPROVING THE COORDINATION AND INTEGRATION OF REENTRY SERVICES. THIS RESEARCH IS HIGHLY RELEVANT TO THE MISSION OF THE NATIONAL INSTITUTE ON DRUG ABUSE (NIDA) AS IT ADDRESSES CRITICAL GAPS IN THE PROVISION AND CARE CONTINUITY OF MOUD, WHICH IS ESSENTIAL FOR REDUCING OPIOID-RELATED MORBIDITY AND MORTALITY AMONG POPULATIONS WITH CRIMINAL LEGAL SYSTEM INVOLVEMENT. BY FOCUSING ON THE SYSTEMIC AND ORGANIZATIONAL FACTORS AFFECTING MOUD ACCESS, THIS PROJECT SEEKS TO CREATE A MORE EFFECTIVE AND EQUITABLE REENTRY SYSTEM THAT SUPPORTS THE HEALTH AND RECOVERY OF FORMERLY INCARCERATED INDIVIDUALS.

Posted 4/17/25